Read the following paragraph to answer questions below--A potential pill to treat stuttering took a step forward yesterday when Indevus Pharmaceuticals Inc. of Lexington said its experimental drug reduced stuttering in a majority of patients in its first clinical trial. The 132 patient trial is the largest human test ever conducted on a drug for stuttering, according to the company. The Indevus drug, called pagoclone, was given to 88 patients in escalating doeses, with the rest of the trial subjects receiving a placebo. The patients were then tracked using several widely accepted measures of stuttering. On a third rating scale, based on doctors' impressions, the pagoclone patients scored "numerically superior rating" to the pacebo gtoup, but the finding did not reach statistical signigicance.

(1)What are the null and alternative hypotheses? (Write hypotheses in both words and symbolic notation.Include proportion and mean where appropriate one test involves proportions, and the other involves means. Consider a higher numerical value to be superior to a lower numerical value)(2)Should H₀be rejected? Why or why not?